Thorne
Thorne appears in 服装品牌 A&F 寻找中国合作伙伴,付费提前看特朗普帖文服务上线 as the premium nutrition and supplement brand Procter & Gamble agreed to acquire for $3.8 billion. The source says Thorne was founded in 1984 and sells products such as folate, vitamins, and other nutritional supplements.
The source frames Thorne as evidence that large consumer-goods companies see supplement demand as a premium, recurring category. It also highlights valuation acceleration: the episode says Thorne had been acquired in 2023 for $680 million and was expected to reach about $650 million in annual revenue.
Source Position
- Thorne is treated as a high-end supplement brand rather than as a drug company.
- The episode makes the brand a case for Supplement Brand Consolidation and Recurring Supplement Commerce.
- The page keeps revenue and valuation figures source-scoped to the episode and cited reports.
Connections
- Procter & Gamble - buyer in the source.
- Supplement Brand Consolidation, Recurring Supplement Commerce, and Dietary Supplement Regulation - adjacent business and regulatory concepts.
- Supplement Label Accuracy and Third-Party Supplement Testing - trust and verification context.